Quality improvement guidelines for transjugular intrahepatic portosystemic shunt (TIPS)

CardioVascular and Interventional Radiology

Volumn 35, Issue 6, 2012, Pages 1295-1300

  Krajina, Antonin ^a   Hulek, Petr ^a   Fejfar, Tomas ^a   Valek, Vlastimil ^b  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; SPIRONOLACTONE;

ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; CARDIOVASCULAR SURGICAL EQUIPMENT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIGITAL SUBTRACTION ANGIOGRAPHY; ECHOGRAPHY; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIVER VEIN THROMBOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PORTAL VEIN THROMBOSIS; PORTOSYSTEMIC COLLATERAL EMBOLIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REFRACTORY ASCITES; TOTAL QUALITY MANAGEMENT; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VARICOSIS; PORTAL HYPERTENSION; STANDARD;

HUMANS; HYPERTENSION, PORTAL; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; QUALITY IMPROVEMENT;

EID: 84878255681     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-012-0493-y     Document Type: Article

References (25)

1. Rösch J, Hanafee WN, Snow H (1969) Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology 92:1112-1114
2. Boyer TD, Haskal ZJ (2010) AASLD practice guidelines: the role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. Hepatology 51:1-16
3. Stankovic Z, Frydrychowicz A, Csatari Z et al (2010) MR-based visualization and quantification of three-dimensional flow characteristics in the portal venous system. J Magn Reson Imaging 32:466-475
4. Runyon BA (2009) Management of adult patients with ascites due to cirrhosis: an update. Hepatology 49:2087-2107
5. Harrod-Kim P, Saad W, Waldman D (2006) Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites. J Vasc Interv Radiol 17:1605-1610
6. Strauss RM, Boyer TD (1997) Hepatic hydrothorax. Semin Liver Dis 17:227-232
7. Senzolo M, Cholongitas E, Davies N et al (2006) Transjugular intrahepatic portosystemic shunt (TIPS), the preferred therapeutic option for Budd Chiari syndrome associated with portal vein thrombosis. Am J Gastroenterol 101:2163-2164
8. Michl P, Gulberg V, Bilzer M et al (2000) Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: effects in patients with organic functional renal failure. Scand J Gastroenterol 35:654-657
9. Azoulay D, Castaing D, Dennison A et al (1994) Transjugular intrahepatic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study. Hepatology 19:129-132
10. Maleux G, Nevens F, Heye S et al (2006) The use of carbon dioxide wedged hepatic venography to identify the portal vein: comparison with direct catheter portography with iodinated contrast medium and analysis of predictive factors influencing level of opacification. J Vasc Interv Radiol 17:1771-1779
11. Krajina A, Lojik M (2001) TIPS technique. In: Hulek P, Krajina A (eds) Current practice of TIPS. Olga Stambergova, Hradec Kralove, pp 56-120
12. Zizka J, Elias P, Krajina A et al (2000) Value of Doppler sonography in revealing transjugular intrahepatic portosystemic shunt malfunction: a 5-year experience in 216 patients. Am J Roentgenol 175:141-148
13. Carr CE, Tuite CM, Soulen MC et al (2006) Role of ultrasound surveillance of transjugular intrahepatic portosystemic shunts in the covered stent era. J Vasc Interv Radiol 17:1297-1305
14. Bass NM, Mullen KD, Sanyal A et al (2010) Rifaximin treatment in hepatic encephalopathy. N Engl J Med 362:1071-1081
15. Riggio O, Angeloni S, Salvatori FM et al (2008) Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol 103:2738-2746
16. Bureau C, Garcia-Pagan JC, Otal P et al (2004) Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 126:469-475
17. Rössle M, Siegerstetter V, Euringer W et al (2006) The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): long-term follow-up of 100 patients. Acta Radiologica 7:660-666
18. Riggio O, Ridola L, Lucidi C, Angeloni S (2010) Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: time to update the guidelines? Dig Liver Dis 42:462-467
19. Jirkovsky V, Fejfar T, Safka V et al (2011) Influence of the secondary deployment of expanded polytetrafluoroethylene-covered stent grafts of maintenance of transjugular intrahepatic portosystemic shutn patency. J Vasc Interv Radiol 22:55-60
20. Rössle M, Ochs A, Gulberg V et al (2000) A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 342:1701-1707
21. Salerno F, Camma C, Enea M et al (2007) Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology 133:825-834
22. Saugel B, Phillip V, Gaa J et al (2012) Advanced hemodynamic monitoring before and after transjugular intrahepatic portosystemic shunt: implication for selection of patients - a prospective study. Radiology 262:343-352
23. Garcia-Pagan JC, Caca K, Bureau C et al (2010) Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 362:2370-2379
24. Garcia-Pagan JC, Heydtmann M, Raffa S et al (2008) TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 135:808-815
25. Barton RE, Rösch J, Saxon RR et al (1995) TIPS: short- and long-term results: a survey of 1750 patients. Semin Interv Radiol 12:346-367